Positron Emission Tomography (PET) is a functional neuroimaging technique used as part of the pre-surgical assessment for pharmacoresistant epilepsy. Unlike structural imaging (such as MRI), PET provides information about how the brain is functioning by detecting areas of altered metabolic activity.
This method falls under the field of nuclear medicine. During the examination, the patient is given a radiopharmaceutical, which accumulates more intensely in areas affected by seizures. These areas are then visualized using specialized scanning equipment, helping to localize the seizure focus.